These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34647008)

  • 21. Airway clearance techniques for bronchiectasis.
    Lee AL; Burge AT; Holland AE
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008351. PubMed ID: 26591003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Airway clearance techniques used by people with cystic fibrosis in the UK.
    Hoo ZH; Daniels T; Wildman MJ; Teare MD; Bradley JM
    Physiotherapy; 2015 Dec; 101(4):340-8. PubMed ID: 25910514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of high-frequency chest wall oscillation and oscillating positive expiratory pressure in the home management of cystic fibrosis: a pilot study.
    Oermann CM; Sockrider MM; Giles D; Sontag MK; Accurso FJ; Castile RG
    Pediatr Pulmonol; 2001 Nov; 32(5):372-7. PubMed ID: 11596162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive expiratory pressure and oscillatory positive expiratory pressure therapies.
    Myers TR
    Respir Care; 2007 Oct; 52(10):1308-26; discussion 1327. PubMed ID: 17894901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of oscillating positive expiratory pressure therapy in adults with stable non-cystic fibrosis bronchiectasis: A systematic review.
    Lee AL; Williamson HC; Lorensini S; Spencer LM
    Chron Respir Dis; 2015 Feb; 12(1):36-46. PubMed ID: 25518845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive clearance of airway secretions.
    Hardy KA; Anderson BD
    Respir Care Clin N Am; 1996 Jun; 2(2):323-45. PubMed ID: 9390886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-invasive ventilation for cystic fibrosis.
    Moran F; Bradley JM; Piper AJ
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002769. PubMed ID: 28218802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial contamination of non-invasive ventilation devices used by adults with cystic fibrosis.
    Mutagi A; Nash EF; Cameron S; Abbott G; Agostini P; Whitehouse JL; Honeybourne D; Boxall E
    J Hosp Infect; 2012 Jun; 81(2):104-8. PubMed ID: 22579442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pressures and Oscillation Frequencies Generated by Bubble-Positive Expiratory Pressure Devices.
    Santos MD; Milross MA; Eisenhuth JP; Alison JA
    Respir Care; 2017 Apr; 62(4):444-450. PubMed ID: 28143962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cystic fibrosis: instrumental airway clearance techniques].
    Reychler G; Coppens T; Leonard A; Palem A; Lebecque P
    Rev Mal Respir; 2012 Feb; 29(2):128-37. PubMed ID: 22405108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autogenic drainage for airway clearance in cystic fibrosis.
    McCormack P; Burnham P; Southern KW
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009595. PubMed ID: 28984368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive expiratory pressure (PEP) therapy. What pressures do we achieve in young children with cystic fibrosis? A single-centre study.
    Kiernan N; Johnstone B; Anderson P; Stewart R
    BMJ Paediatr Open; 2020; 4(1):e000792. PubMed ID: 33409382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive Ventilation as Airway Clearance Technique in Cystic Fibrosis.
    Rodriguez Hortal MC; Nygren-Bonnier M; Hjelte L
    Physiother Res Int; 2017 Jul; 22(3):. PubMed ID: 26929396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manometry Optimized Positive Expiratory Pressure (MOPEP) in Excessive Dynamic Airway Collapse (EDAC).
    Zafar MA; Mulhall AM; Eschenbacher W; Kaul A; Benzaquen S; Panos RJ
    Respir Med; 2017 Oct; 131():179-183. PubMed ID: 28947026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of the addition of a new airway clearance device to chest physiotherapy in children with cystic fibrosis pulmonary exacerbations.
    Walicka-Serzysko K; Postek M; Jeneralska N; Cichocka A; Milczewska J; Sands D
    J Mother Child; 2021 Jan; 24(3):16-24. PubMed ID: 33544556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial contamination of cystic fibrosis clinics.
    Zuckerman JB; Zuaro DE; Prato BS; Ruoff KL; Sawicki RW; Quinton HB; Saiman L;
    J Cyst Fibros; 2009 May; 8(3):186-92. PubMed ID: 19250885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability in expiratory flow requirements among oscillatory positive expiratory pressure.
    Morgan SE; Mosakowski S; Giles BL; Naureckas E; Tung A
    Can J Respir Ther; 2019; 56():7-10. PubMed ID: 32181326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologic evidence for the efficacy of positive expiratory pressure as an airway clearance technique in patients with cystic fibrosis.
    Darbee JC; Ohtake PJ; Grant BJ; Cerny FJ
    Phys Ther; 2004 Jun; 84(6):524-37. PubMed ID: 15161418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007923. PubMed ID: 33686652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate changes in blood-gas tensions during chest physiotherapy with positive expiratory pressure and oscillating positive expiratory pressure in patients with cystic fibrosis.
    Lagerkvist AL; Sten GM; Redfors SB; Lindblad AG; Hjalmarson O
    Respir Care; 2006 Oct; 51(10):1154-61. PubMed ID: 17005061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.